D-1214-2018 Class III Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-1214-2018 was initiated by LUPIN SOMERSET on Aug 23, 2018 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month… The recall status is terminated (terminated Oct 14, 2022). Affected quantity: 4716 bottle.

Recall details

Product Type
Drugs
Report Date
Sep 26, 2018
Initiation Date
Aug 23, 2018
Termination Date
Oct 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4716 bottle

Product description

Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01

Reason for recall

Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.

Distribution pattern

U.S.A. Nationwide

Code information

Lot# S800232, Exp 2/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1214-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1214-2018. Report a data issue: hello@regdatalab.com.